CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485,567 | +7.9% | 162,993 | +33.0% | 0.01% | -26.7% |
| Q2 2023 | $4,158,189 | +65.5% | 122,552 | +75.5% | 0.02% | -60.5% |
| Q1 2023 | $2,511,980 | -34.4% | 69,816 | -18.8% | 0.04% | -44.9% |
| Q4 2022 | $3,831,772 | -20.7% | 85,972 | -50.0% | 0.07% | -25.0% |
| Q3 2022 | $4,832,000 | +279.6% | 171,902 | +359.9% | 0.09% | +170.6% |
| Q1 2022 | $1,273,000 | +131.5% | 37,381 | +162.7% | 0.03% | +100.0% |
| Q4 2021 | $550,000 | – | 14,227 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |